|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
3/16/2006 11:57:35 AM
ZURICH, March 16 (Reuters) - Swiss drug maker Roche Holding AG said on Thursday it had signed up new production partners to help it increase annual production of its flu medicine Tamiflu by 100 million treatments. This would bring total production capacity to 400 million treatments a year by the end of 2006. Production partners include Albemarle Corp , Ampac Fine Chemicals LLC, API Corp, Clariant , DSM , FIS, Martek Biosciences Corp , Novasep/Dynamit Nobel, PHT International, PPG Industries , Sanofi-Aventis , Shaanxi Jiahe Phytochem Co, Siegfried Ltd . Previously announced partners: Hetero Drugs, Shanghai Pharmaceuticals.
|
|
|
|
|
|
|
|
|
|
|